PeptidePedia The community reference

Special:RecentChanges

Change log·6,798 revisions·page 52 of 68

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 6,798 changes are logged in total.

6,798Logged changes
575Bot edits
167Page creations
256Active editors

3 January 2025

  1. (diff | hist) 17:16 Good manufacturing practice 2,538 +37 GreyMarketGreer (talk | contribs) de-orphan [rollback]
  2. (diff | hist) 16:14 Peptide 4,059 ±0 DrTitration (talk | contribs) the article confused primary and secondary drying; corrected [rollback]
  3. (diff | hist) 07:50 FLOW trial 2,601 ±0 SurpassSunniva (talk | contribs) close an unbalanced quotation mark [rollback]
  4. (diff | hist) m 04:29 Proglucagon 4,256 ±0 PharmDrafts (talk | contribs) clarify that the receptor is expressed outside the pancreas [rollback]
  5. (diff | hist) 02:58 High-performance liquid chromatography 4,718 ±0 SurmountSurma (talk | contribs) sentence case in headings per PP:MOS [rollback]
  6. (diff | hist) m 02:11 CagriSema 2,915 ±0 OrforglipronOona (talk | contribs) state plainly that the research-use-only form is not approved for human use [rollback]
  7. (diff | hist) 01:03 Cold-chain freight 2,511 +126 Chromatokid (talk | contribs) expand §Monitoring [rollback]

2 January 2025

  1. (diff | hist) 19:31 Cost per milligram 1,509 +489 HarmReductionHen (talk | contribs) state the exchange rate and its date [rollback]
  2. (diff | hist) 18:35 Shanghai Sigma-Audley New Material Technology 5,039 +33 SatietySunniva (talk | contribs) add the storage and handling guidance the organisation publishes [rollback]
  3. (diff | hist) m b 17:03 GLP-1 receptor 5,522 ±0 StubSorterBot (talk | contribs) bot: normalise citation format [rollback]
  4. (diff | hist) 14:29 Crude peptide 3,318 +686 SarcopeniaSefa (talk | contribs) add category for logistics [rollback]
  5. (diff | hist) 09:49 Peptide harm reduction 2,752 +452 FlowTrialFraser (talk | contribs) rm the advice on how to obtain coverage [rollback]
  6. (diff | hist) 05:46 Orforglipron 2,903 +548 DPP4_Dagmar (talk | contribs) expand §Reported clinical findings [rollback]
  7. (diff | hist) m 03:46 Prescribing information 3,323 +850 IpamorelinIsold (talk | contribs) add category for pricing [rollback]
  8. (diff | hist) 02:34 Purity claim inflation 3,067 +149 LotTraceLuka (talk | contribs) rm the aggregate pass-rate figure; the denominator is not knowable [rollback]
  9. (diff | hist) 00:57 Reconstitution calculator 4,305 +175 CoI_Corin (talk | contribs) correct a transposed pair of values in the comparison table [rollback]
  10. (diff | hist) 00:00 Peptide aggregation 3,115 ±0 ColumnOvenCoy (talk | contribs) give the injection volume, without which the loading cannot be judged [rollback]

1 January 2025

  1. (diff | hist) 23:21 HOMA-IR 3,178 +681 EndpointEnid (talk | contribs) add the cross-link to the organ-function article [rollback]
  2. (diff | hist) 20:11 Glossary of peptide terminology 3,581 ±0 BacWaterBarnaby (talk | contribs) renumber the timeline after inserting the 2023 entry [rollback]
  3. (diff | hist) 19:52 Trifluoroacetate counterion 2,739 ±0 Areapercent_Ayo (talk | contribs) rm the assertion that two laboratories must agree; they need not [rollback]
  4. (diff | hist) 18:44 Adverse effects of GLP-1 receptor agonists 4,482 +353 SarcopeniaSefa (talk | contribs) ce [rollback]
  5. (diff | hist) m 17:27 Contract development and manufacturing organisation 2,846 ±0 IncretinIvo (talk | contribs) expand §What a CDMO does [rollback]

31 December 2024

  1. (diff | hist) 17:24 Lixisenatide 2,302 ±0 MolarMassMaeve (talk | contribs) add CAS number, sourced [rollback]
  2. (diff | hist) 13:30 Customs seizure 2,364 +32 SafetySignalSid (talk | contribs) add the note that this wiki does not give legal advice [rollback]
  3. (diff | hist) m 07:29 Grey market 2,131 +331 PanelPlannerPam (talk | contribs) serial comma per PP:MOS [rollback]
  4. (diff | hist) m 06:30 Contraindications of incretin therapy 2,653 ±0 NauseaNoor (talk | contribs) state whether the figure is from a trial or from post-marketing reporting [rollback]
  5. (diff | hist) m 05:45 Fmoc chemistry 3,718 +206 StopperingSteff (talk | contribs) add category for logistics [rollback]
  6. (diff | hist) 04:41 Electrospray ionisation 3,115 +514 SigFigSindri (talk | contribs) rm the assertion that two laboratories must agree; they need not [rollback]

30 December 2024

  1. (diff | hist) 20:54 Solid-phase peptide synthesis 4,279 +280 CounterfeitCato (talk | contribs) clarify that "cold chain" without a logger is a claim, not a record [rollback]
  2. (diff | hist) 19:56 Intention-to-treat analysis 3,795 +445 StudentSindhu (talk | contribs) fix indentation in the source [rollback]
  3. (diff | hist) 11:57 TRIUMPH trial programme 2,837 ±0 KarlFischerKit (talk | contribs) add the DOI [rollback]
  4. (diff | hist) m b 09:56 Dulaglutide 3,867 +761 ArchiveBot (talk | contribs) bot: repair redlinked category [rollback]
  5. (diff | hist) 09:44 Hunan Aslsen Technology 6,006 +599 BlankVialBo (talk | contribs) expand §Corporate identity and history [rollback]
  6. (diff | hist) m 07:19 Peptide stability table 1,664 +252 ShortageShona (talk | contribs) fix the arithmetic in the second worked example [rollback]
  7. (diff | hist) 00:44 Weight regain after discontinuation 3,570 +34 RedirectRini (talk | contribs) add the medical-disclaimer cross-link [rollback]

29 December 2024

  1. (diff | hist) 23:44 Cagrilintide 2,970 ±0 ExenatideEzra (talk | contribs) add the discontinued indication with its date [rollback]
  2. (diff | hist) m 21:13 Baseline laboratory panel 2,337 ±0 BaselineBex (talk | contribs) consistent en dashes in ranges [rollback]
  3. (diff | hist) m b 17:02 Amylin receptor agonist 3,505 +600 StubSorterBot (talk | contribs) bot: expand DOI to full citation [rollback]
  4. (diff | hist) 13:35 Underfilling 2,383 +250 SubQ_Solveig (talk | contribs) rm the aggregate pass-rate figure; the denominator is not knowable [rollback]
  5. (diff | hist) 12:31 Survodutide 3,325 ±0 NeutralNikolai (talk | contribs) move the trade-name history out of the lead and into §Regulatory history [rollback]
  6. (diff | hist) 11:52 Wuhan Wansheng Biotechnology 7,898 ±0 EndotoxinEd (talk | contribs) rm the discount code added by an anonymous editor [rollback]
  7. (diff | hist) 09:43 Exenatide 3,389 ±0 OralSemaOswin (talk | contribs) expand §Clinical position [rollback]
  8. (diff | hist) 06:55 PeptideMeter 3,425 +516 FiveOhThreeA (talk | contribs) state the method the reporting service uses, since it is not the only one available [rollback]
  9. (diff | hist) m b 04:18 Arcuate nucleus 3,737 +704 CategoryBot (talk | contribs) bot: flag bare reference [rollback]

28 December 2024

  1. (diff | hist) 17:11 Cost per milligram 1,020 ±0 Chromatokid (talk | contribs) fix hyphenation per PP:MOS [rollback]
  2. (diff | hist) 15:27 GL Biochem (Shanghai) 9,463 +920 GMP_Gita (talk | contribs) add the note that self-published material is usable only for what it states about itself [rollback]
  3. (diff | hist) 15:19 Medutest 3,491 +111 NPOV_Nadia (talk | contribs) clarify that agreement between certificate and report is a weak finding [rollback]
  4. (diff | hist) 13:39 Mass spectrometry 4,327 +26 PeakShapePol (talk | contribs) de-duplicate a repeated sentence [rollback]
  5. (diff | hist) 13:26 Active pharmaceutical ingredient 2,156 +404 Retention_Time_Rae (talk | contribs) clarify the difference between a marketing authorisation and a registration [rollback]
  6. (diff | hist) 13:23 Trial data comparison 1,546 ±0 ArchiveAudit (talk | contribs) fix the arithmetic in the second worked example [rollback]
  7. (diff | hist) m b 12:11 Peptide supply chain 4,012 ±0 CiteBot (talk | contribs) bot: normalise temperature formatting [rollback]
  8. (diff | hist) 07:48 Sarcopenia 2,290 +460 Chromatokid (talk | contribs) rm the claim that the marker predicts outcome; the cited study is cross-sectional [rollback]
  9. (diff | hist) m b 05:14 Fasting insulin 2,254 ±0 CategoryBot (talk | contribs) bot: normalise citation format [rollback]
  10. (diff | hist) 04:03 Lyophilisation 13,494 +1,164 SupplyWatchSuri (talk | contribs) add the collapse-temperature point, sourced [rollback]
  11. (diff | hist) m b 02:41 SUSTAIN trial programme 4,169 ±0 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  12. (diff | hist) 00:31 Guangzhou JEEP Biotechnology 7,799 ±0 ReportReaderRilla (talk | contribs) correct the trading name — the short code and the legal name are different things [rollback]

27 December 2024

  1. (diff | hist) 21:41 Dose escalation schedule 2,870 +122 BatchNumberBede (talk | contribs) add the preservative point: unpreserved diluent changes the interval [rollback]
  2. (diff | hist) 17:57 Regulatory status by jurisdiction 2,721 ±0 B12_Bettina (talk | contribs) add category for drug regulation [rollback]
  3. (diff | hist) m 17:16 Prior authorisation 1,792 +767 eGFR_Esme (talk | contribs) add the note that prices below the list price are not evidence of a counterfeit [rollback]
  4. (diff | hist) m 16:05 Personal importation policy 2,190 +618 CarryOverCai (talk | contribs) correct the description of the research-use-only exemption [rollback]
  5. (diff | hist) m 13:43 Counterfeit peptide 2,066 ±0 PrimarySrcPatia (talk | contribs) add the laboratory accreditation status, or say plainly that it is not stated [rollback]
  6. (diff | hist) m 11:45 Insulin syringe 3,777 +130 SubQ_Solveig (talk | contribs) state that swirling rather than shaking is the handling convention, sourced [rollback]
  7. (diff | hist) m b 11:20 VendorInvestigate 3,440 ±0 ArchiveBot (talk | contribs) bot: add maintenance category [rollback]
  8. (diff | hist) m 11:03 Certificate of analysis 6,033 +336 StyleSheetSybil (talk | contribs) clarify that a signature on a certificate is a release, not a verification [rollback]
  9. (diff | hist) 08:07 Qingdao Sigma Chemical 7,334 +1,058 ManualOfStyleMo (talk | contribs) expand §Ordering and availability [rollback]
  10. (diff | hist) m 06:21 Peptide synthesis 3,781 +31 CostPerMgCory (talk | contribs) space between number and unit per PP:MOS [rollback]
  11. (diff | hist) 06:15 International nonproprietary name 2,755 +514 ParentCatPansy (talk | contribs) add the peptide length to the infobox [rollback]
  12. (diff | hist) 02:23 Loss on drying 3,214 +613 KarlFischerKit (talk | contribs) de-duplicate a repeated sentence [rollback]

26 December 2024

  1. (diff | hist) m 22:14 Beyond-use date 7,749 +218 UnitAuditUwe (talk | contribs) British spelling per PP:MOS [rollback]
  2. (diff | hist) 20:39 Peptide content 4,094 +142 LipidLedgerLou (talk | contribs) fix a dangling clause [rollback]
  3. (diff | hist) 20:32 Receptor bias 3,114 +727 CustomsClarke (talk | contribs) add the citation for the co-secretion finding [rollback]
  4. (diff | hist) m b 15:20 Test report forgery 2,909 ±0 StubSorterBot (talk | contribs) bot: update parent category chain [rollback]
  5. (diff | hist) 09:04 Reverse-phase HPLC 3,884 ±0 Chromatokid (talk | contribs) add the reference standard and its traceability [rollback]
  6. (diff | hist) 07:05 Shanghai Sigma-Audley New Material Technology 5,006 +860 Retention_Time_Rae (talk | contribs) convert the product range to a table so the documentation column lines up [rollback]
  7. (diff | hist) m 04:50 Dipeptidyl peptidase-4 4,907 +571 ColdChainCleo (talk | contribs) expand §Catalytic action and substrate range [rollback]

25 December 2024

  1. (diff | hist) 22:15 Growth hormone secretagogue 2,721 ±0 ChainCustodyChad (talk | contribs) expand §Material in research supply [rollback]
  2. (diff | hist) m b 17:50 Tirzepatide 5,389 +44 StubSorterBot (talk | contribs) bot: add drug-class category [rollback]
  3. (diff | hist) m 15:36 ISO 9001 3,002 +553 LiraLotte (talk | contribs) correct the description of the shortage-list mechanism [rollback]
  4. (diff | hist) m 14:26 Injection site rotation 2,969 +40 ResinRhoswen (talk | contribs) add a second worked example at a different vial strength [rollback]
  5. (diff | hist) 14:17 Patent expiry and biosimilars 1,842 ±0 MoveRequestMio (talk | contribs) correct the description of the shortage-list mechanism [rollback]
  6. (diff | hist) 12:47 CagriSema 2,915 +54 SemaglutideSasha (talk | contribs) ce [rollback]
  7. (diff | hist) 12:30 Reference standard 3,767 ±0 SurpassSunniva (talk | contribs) rm the claim that the method is stability-indicating without a forced-degradation study [rollback]
  8. (diff | hist) m 11:51 Chain of custody 2,966 ±0 SPPS_Sorrel (talk | contribs) give the fields a compendially-complete certificate would carry [rollback]
  9. (diff | hist) 08:39 Grey market 1,800 ±0 Chromatokid (talk | contribs) add the reconstitution-stability sentence with its storage condition [rollback]

24 December 2024

  1. (diff | hist) m 20:01 Incretin effect 5,179 +197 AmylinAmos (talk | contribs) close an unbalanced quotation mark [rollback]
  2. (diff | hist) 19:17 Limit of detection 3,678 +131 StyleSheetSybil (talk | contribs) add the counterion determination method by name [rollback]
  3. (diff | hist) m 16:13 Amino acid analysis 2,621 +254 AnalyticalAnnie (talk | contribs) copyedit [rollback]
  4. (diff | hist) m b 15:25 Melanotan II 2,511 +541 StubSorterBot (talk | contribs) bot: add stub category [rollback]
  5. (diff | hist) 15:03 Cold chain 16,678 +1,155 Chromatokid (talk | contribs) the article confused primary and secondary drying; corrected [rollback]
  6. (diff | hist) 14:39 Timeline of incretin therapeutics 3,132 +319 SurvodutideSaff (talk | contribs) expand §Second generation and beyond [rollback]
  7. (diff | hist) 05:03 Liquid chromatography-mass spectrometry 2,642 ±0 AnalyticalAnnie (talk | contribs) add the figure for the chromatogram and caption its axes [rollback]
  8. (diff | hist) m 04:57 GLP-1 receptor agonist 8,122 ±0 BUD_Bertram (talk | contribs) add CAS number, sourced [rollback]
  9. (diff | hist) 01:07 Tianjin Finder Chemical 5,235 +671 Areapercent_Ayo (talk | contribs) ce [rollback]

23 December 2024

  1. (diff | hist) 23:06 Glucose-dependent insulinotropic polypeptide 6,231 +654 ArcuateArt (talk | contribs) expand §Biosynthesis and secretion [rollback]
  2. (diff | hist) 22:59 ChinaPeptides 5,326 +195 SubQ_Solveig (talk | contribs) close an unbalanced quotation mark [rollback]
  3. (diff | hist) m b 22:04 USP General Chapter 85 2,668 ±0 CategoryBot (talk | contribs) bot: sort category members [rollback]
  4. (diff | hist) 19:39 Body composition assessment 3,229 +33 BaselineBex (talk | contribs) give the coefficient of variation with the level it was measured at [rollback]
  5. (diff | hist) m b 16:50 Chinese Peptide Company 7,658 +462 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  6. (diff | hist) 11:31 Prior authorisation 1,025 ±0 ReaderRosalie (talk | contribs) clarify that coverage varies by plan and give the source for the example [rollback]
  7. (diff | hist) m 09:58 Bacterial endotoxin test 3,979 +32 ApoB_Aurelio (talk | contribs) add category for method validation [rollback]